Royal London Asset Management’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$310M Sell
745,305
-10,284
-1% -$3.81M 0.57% 25
2026
Q1
$204M Buy
755,589
+5,344
+0.7% +$1.59M 0.43% 38
2025
Q4
$248M Sell
750,245
-5,766
-0.8% -$1.95M 0.52% 27
2025
Q3
$261M Sell
756,011
-15,460
-2% -$4.68M 0.56% 27
2025
Q2
$241M Sell
771,471
-558,518
-42% -$213M 0.55% 29
2025
Q1
$697M Buy
1,329,989
+24,426
+2% +$12.5M 1.65% 9
2024
Q4
$660M Sell
1,305,563
-16,266
-1% -$9.24M 1.61% 9
2024
Q3
$773M Sell
1,321,829
-139,255
-10% -$78.8M 1.9% 7
2024
Q2
$744M Sell
1,461,084
-134,158
-8% -$65.8M 1.9% 7
2024
Q1
$789M Buy
1,595,242
+120,843
+8% +$61.4M 1.97% 7
2023
Q4
$776M Sell
1,474,399
-9,443
-0.6% -$5.04M 2.22% 7
2023
Q3
$748M Buy
1,483,842
+94,826
+7% +$46.7M 2.42% 6
2023
Q2
$667M Buy
1,389,016
+184,500
+15% +$90.2M 2.16% 7
2023
Q1
$569M Buy
1,204,516
+287,010
+31% +$139M 2.28% 6
2022
Q4
$487M Buy
917,506
+161,534
+21% +$85.6M 2.18% 6
2022
Q3
$382M Sell
755,972
-12,876
-2% -$6.77M 1.94% 7
2022
Q2
$396M Buy
768,848
+32,750
+4% +$16.4M 1.83% 7
2022
Q1
$375M Buy
736,098
+36,687
+5% +$17.7M 1.47% 9
2021
Q4
$351M Buy
699,411
+16,867
+2% +$7.64M 1.31% 12
2021
Q3
$267M Buy
682,544
+6,409
+0.9% +$2.65M 1.08% 16
2021
Q2
$271M Buy
676,135
+158,916
+31% +$63.4M 1.1% 16
2021
Q1
$193M Buy
517,219
+15,268
+3% +$5.29M 0.88% 19
2020
Q4
$176M Sell
501,951
-2,256
-0.4% -$756K 0.92% 19
2020
Q3
$153M Sell
504,207
-1,070
-0.2% -$329K 0.93% 20
2020
Q2
$146M Sell
505,277
-12,498
-2% -$3.58M 1.02% 14
2020
Q1
$130M Buy
517,775
+5,097
+1% +$1.4M 1.05% 13
2019
Q4
$151M Buy
512,678
+9,442
+2% +$2.47M 1.04% 14
2019
Q3
$109M Sell
503,236
-5,411
-1% -$1.31M 0.83% 17
2019
Q2
$124M Buy
508,647
+6,596
+1% +$1.59M 1.17% 11
2019
Q1
$124M Sell
502,051
-19,985
-4% -$5.1M 0.98% 15
2018
Q4
$129M Buy
522,036
+89,061
+21% +$23.5M 1.13% 12
2018
Q3
$115M Sell
432,975
-4,193
-1% -$1.09M 1.18% 11
2018
Q2
$107M Buy
+437,168
New +$105M 1.08% 12
2016
Q2
$49.4M Sell
349,694
-29,889,704
-99% -$3.99B 0.81% 27
2016
Q1
$235K Buy
30,239,398
+29,860,138
+7,873% +$3.53B 0.34% 66
2015
Q4
$45.1M Buy
379,260
+169
+0% +$19.8K 0.7% 31
2015
Q3
$44M Buy
+379,091
New +$45.4M 0.71% 31
2014
Q4
$358K Buy
347,753
+64,989
+23% +$6.16M 0.68% 31
2014
Q3
$24.5M Buy
282,764
+7,128
+3% +$602K 0.61% 32
2014
Q2
$22.5M Sell
275,636
-2,267
-0.8% -$178K 0.52% 38
2014
Q1
$21.6M Buy
277,903
+37,432
+16% +$2.82M 0.5% 43
2013
Q4
$18M Buy
240,471
+2,297
+1% +$165K 0.46% 52
2013
Q3
$16.1M Buy
238,174
+2,545
+1% +$182K 0.43% 52
2013
Q2
$15.6M Buy
+235,629
New +$14.7M 0.45% 48

Other funds holding UNH

Royal London Asset Management's UNH Position: Q2 2026 in Review

Royal London Asset Management reduced its UnitedHealth (UNH) stake by 1.4% in Q2 2026, selling an estimated $3.81M and leaving 745,305 shares worth $310M. The position accounts for 0.57% of the portfolio, ranked #25.

Royal London Asset Management first reported a position in UNH in Q2 2013 and has held it in 44 quarters since. The position peaked at $789M in Q1 2024. 3,367 funds tracked by Wall St. Rank hold UNH as of Q2 2026.

  • Royal London Asset Management held 745,305 shares of UnitedHealth worth $310M as of Q2 2026.
  • Royal London Asset Management sold 10,284 UnitedHealth shares in Q2 2026, an estimated $3.81M.
  • UnitedHealth made up 0.57% of Royal London Asset Management's portfolio in Q2 2026, its #25 holding.
  • Royal London Asset Management first reported a position in UnitedHealth in Q2 2013 and has held it in 44 quarters since.
  • Royal London Asset Management's UnitedHealth position peaked at $789M in Q1 2024.
  • 3,367 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.

Based on Royal London Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.